Research | Division of Urologic Surgery

Epigenetic underpinnings of tumor-immune dynamics in prostate cancer immune suppression (Links to an external site)

February 13, 2024February 13, 2024

Duminduni Hewa Angappulige, Nupam and Kiran Mahajan.

Research technician Duminduni Hewa Angappulige joined Kiran Mahajan, PhD, and Nupam Mahajan, to discuss how de novo epigenetic alterations drive resistance and how efforts aimed at targeting these regulators may overcome immune suppression observed in prostate cancer. Read the article just published in Trends in Cancer.

Drug triggers immune cells to attack prostate cancer (Links to an external site)

November 22, 2022November 22, 2022

Compound kills tumors in mice, human cancer cells in multiple ways.

A Smart Way to Prevent Kidney Stones (Links to an external site)

July 7, 2021July 19, 2021

Washington University urologic surgeons Henry Lai, MD, and Alana Desai, MD, joined forces with the Urinary Stone Disease Research Network to determine if behavioral interventions, like drinking more water, can prevent kidney stones.